Back to top

WARRANT TO PURCHASE 119,355 SHARES OF COMMON STOCK

Warrant Agreement

WARRANT TO PURCHASE 119,355 SHARES OF

                                  COMMON STOCK | Document Parties: ALTUS BIOLOGICS INC. | Altus Pharmaceuticals Inc You are currently viewing:
This Warrant Agreement involves

ALTUS BIOLOGICS INC. | Altus Pharmaceuticals Inc

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: WARRANT TO PURCHASE 119,355 SHARES OF COMMON STOCK
Governing Law: Massachusetts     Date: 10/17/2005

WARRANT TO PURCHASE 119,355 SHARES OF

                                  COMMON STOCK, Parties: altus biologics inc. , altus pharmaceuticals inc
50 of the Top 250 law firms use our Products every day

 

<PAGE>

                                                                    Exhibit 4.12

 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS

AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS (A)

COVERED BY AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT, (B) THE COMPANY

HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE

COMPANY TO THE EFFECT THAT NO REGISTRATION IS REQUIRED FOR SUCH TRANSFER OR (C)

SUCH TRANSFER IS MADE IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER

THE ACT. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS

IN COMPLIANCE WITH THE ACT.

 

================================================================================

 

Warrant No. W-B __________                                          XXXXXX Shares

 

                                     Form of

                                     WARRANT

           To Purchase Shares of Series B Convertible Preferred Stock

                                        of

                              ALTUS BIOLOGICS INC.

                            Dated September __, 2001

 

================================================================================

 

     WHEREAS, Altus Biologics Inc., a Delaware corporation (the "Company"),

intends to provide the Holder an opportunity to increase its equity interest in

the Company through the acquisition of shares of its Series B Convertible

Preferred Stock, $.0l par value per share ("Series B Stock"), upon the exercise

of a warrant with respect thereto;

 

     NOW, THEREFORE, in consideration of the foregoing and other good and

valuable consideration, the receipt of which is hereby acknowledged, the Company

certifies and agrees as follows:

 

     This Warrant certifies that, for value received, ______________ (the

"Holder"), or registered assigns, is entitled to purchase from the Company XXXXX

(as adjusted from time to time pursuant to Section 6 hereof, the "Original

Number") shares of the fully paid and non-assessable Series B Stock of the

Company, at a price of $4.3147358 per share (the "Exercise Price").

Notwithstanding the foregoing, if the Series B Stock shall prior to exercise or

exchange of this Warrant have been converted into Common Stock, $.01 par value

(the "Common Stock") of the Company as a result of mandatory conversion

("Mandatory Conversion Event") of the Series B Stock as set forth in Article IV,

Section E5 of the Amended and Restated Certificate of Incorporation of the

Company (as the same may be further amended, restated or in effect from time to

time, the "Charter"), then from and after the date of the Mandatory Conversion

Event, this Warrant shall be exercisable for that number of shares of Common

Stock that is equal to the Original Number multiplied by the Conversion Factor

(as defined below). The Conversion Factor shall equal the number of shares of

Common Stock that each share of outstanding Series B Stock converted into on the

date of the Mandatory Conversion Event. Upon the occurrence of the Mandatory

Conversion Event, the Exercise Price then in effect (the "Original Exercise

Price") shall be adjusted to a number that is equal to the Original Exercise

Price divided by the Conversion Factor. This Warrant may be exercised at any

time on or before the "Expiration Date" which shall mean the date that is seven

(7) years after the date hereof. This Warrant is issued as of September __, 2001

(the "Issue Date") pursuant to that certain Series B Convertible Preferred Stock

and Warrant Purchase Agreement dated as of September __, 2001. The shares of

capital stock of the Company issuable upon exercise or exchange of this Warrant

are sometimes hereinafter referred to as the "Warrant Shares," and, in

connection therewith, all references herein to Warrant Shares shall mean Series

B Stock until the occurrence of a Mandatory Conversion Event, and upon and at

all times after, the occurrence of a Mandatory Conversion Event, shall mean

Common Stock. As used herein, the term "Warrant Class" shall mean (i) prior to

the occurrence of the Mandatory Conversion Event, the Series B Stock and (ii)

after the occurrence of the Mandatory Conversion Event, the Common Stock.

<PAGE>

     1. EXERCISE OF WARRANT.

 

     1.1. PROCEDURE. The Holder or any person or entity to whom the Holder has

assigned its rights under this Warrant (collectively referred to as the

"Warrantholder") may exercise this Warrant, at any time or from time to time,

prior to the Expiration Date, on any business day, by surrendering the Warrant,

accompanied by a written notice in the form attached hereto (the "Exercise

Notice"), to the Company at the address designated in Section 8.4 hereof,

exercising this Warrant and specifying the total number of Warrant Shares the

Warrantholder will purchase pursuant to such exercise. This Warrant may be

exercised in whole or in part as to any or all of the Warrant Shares. A

certificate or certificates for the Warrant Shares purchased upon exercise of

this Warrant and, in the event of a partial exercise of this Warrant, a new

Warrant of like tenor representing the balance of Warrant Shares purchasable

hereunder, shall be delivered by the Company to the Warrantholder not later than

ten days after payment is made for the Warrant Shares purchased upon such

partial exercise. No fractions of a share of capital stock will be issued upon

the exercise of this Warrant, but if a fractional share would be issuable upon

exercise, the Company will pay in cash the fair market value thereof as

determined under Section 1.2 below.

 

     1.2. NET EXERCISE FORMULA. The Warrantholder may exercise this Warrant

either (i) by paying to the Company, by cash or check, an amount equal to the

aggregate Exercise Price of the Warrant Shares being purchased, or (ii) by

electing to receive Warrant Shares equal to the value (as determined below) of

this Warrant by surrender of this Warrant together with notice of such election,

in which event the Company shall issue to the Warrantholder a number of Warrant

Shares computed using the following formula:

 

                                    X = Y(A-B)

                                       ------

                                          A

 

Where: X = the number of Warrant Shares to be issued to the Warrantholder.

 

          Y = the number of Warrant Shares under this Warrant (or such lesser

     number of Warrant Shares as the Warrantholder elects to purchase, in the

     case of a partial exercise).

 

          A = the fair market value of one Warrant Share.

 

          B = the Exercise Price.

 

     As used herein, the fair market value of one Warrant Share shall mean:

 

     (i) After the Mandatory Conversion Event (A) (1) if the Common Stock of the

Company is not then traded on a national securities exchange, the average of the

closing prices quoted on the National Association of Securities Dealers, Inc.

Automated Quotation National Market System, if applicable, or the average of the

last bid and asked prices of the Common Stock quoted in the

over-the-counter-market or (2) if the Common Stock is then traded on a national

securities exchange, the average of the high and low prices of the Common Stock

listed on the principal national securities exchange on which the Common Stock

is so traded, in each case for the twenty (20) trading days immediately

preceding the determination date or, if such date is not a business day on which

shares are traded, the next immediately preceding trading day;

 

               (B) in all other circumstances, the fair market value per share

of Common Stock as determined by the Company's Board of Directors in good faith

after taking into consideration all factors it deems appropriate, including,

without limitation, recent sale and offer prices of the capital stock of the

Company in private transactions negotiated at arm's length; provided that in the

event the Warrantholder disagrees with the fair market value determined by the

Board of Directors, the Company and the Warrantholder shall use their best

efforts to agree upon the selection of an independent appraiser, who will have

30 days in which to determine the fair market value of the Common Stock, and

whose determination will be final and binding on all parties concerned with all

costs of such determination to be borne by the Company;

 

     (ii) Prior to the Mandatory Occurrence Event, the fair market value per

share of Series B Stock as determined by the Company's Board of Directors in

good faith after taking into consideration all factors it deems appropriate,

including, without limitation, recent sale and offer prices of the capital stock

of the Company in private

 

 

                                       2

<PAGE>

transactions negotiated at arm's length and the privileges and preferences of

the Series B Stock, provided that in the event the Warrantholder disagrees with

the fair market value determined by the Board of Directors, the Company and the

Warrantholder disagrees with the fair market value determined by the Board of

Directors, the Company and the Warrantholder shall use their best efforts to

agree upon the selection of an independent appraiser, who will have 30 days in

which to determine the fair market value of the Series B Stock, and whose

determination will be final and binding on all parties concerned with all costs

of such determination to be borne by the Company.

 

     1.3. AUTOMATIC EXERCISE. To the extent this Warrant is not previously

exercised, and if the fair market value (as determined in accordance with

Section 1.2 above) of one Warrant Share is greater than the Exercise Price, as

adjusted, this Warrant shall be deemed automatically exercised in accordance

with Section 1.2 hereof (even if not surrendered) immediately prior to the close

of business on the Expiration Date or if such date is not a business day in

Boston, on the business day next preceding the Expiration Date. For purposes of

such automatic exercise, the fair market value of one Warrant Share shall be the

fair market value determined pursuant to Section 1.2 above. To the extent this

Warrant or any portion thereof is deemed automatically exercised pursuant to

this Section 1.3, the Company agrees to notify Warrantholder within a reasonable

period of time of the number of shares of the Company's capital stock, if any,

the Warrantholder is to receive by reason of such automatic exercise. The

Company shall not be required to deliver any share certificates evidencing any

shares of capital stock issuable upon such automatic exercise unless and until

the Company has received the original of this Warrant or a Lost Warrant

Certificate (as defined below).

 

     1.4. LOST, STOLEN, MUTILATED OR DESTROYED WARRANT. If this Warrant is lost,

stolen mutilated or destroyed, the Company may require the Warrantholder to

provide a certificate ("Lost Warrant Certificate"), which may contain terms as

to indemnity or otherwise as it may require in its reasonable discretion (which

shall, in the case of a mutilated Warrant, include the surrender thereof), issue

a replacement Warrant of like denomination and tenor as the Warrant so lost,

stolen, mutilated or destroyed.

 

     2. RECORD HOLDER. A Warrant shall be deemed to have been exercised

immediately prior to the close of business on the date of its surrender for

exercise as provided in Section 1.1 above and the person entitled to receive the

Warrant Shares issuable upon such exercise or conversion shall be treated for

all purposes as the holder of such Warrant Shares of record as of the close of

business on such date. In the event of an automatic exercise pursuant to Section

1.3 above, the person entitled to receive the Warrant Shares shall be treated

for all purposes as the holder of such Warrant Shares of record as of the close

of business on the Expiration Date.

 

     3. PAYMENT OF TAXES. The Company shall pay all taxes and other governmental

charges (other than income taxes) that may be imposed in respect of the issue of

delivery of the Warrant Shares or any portion thereof. The Company shall not be

required, however, to pay any tax or other charge imposed in connection with any

transfer involved in the issue of any certificate for the Warrant Shares or any

portion thereof in any name other than that of the registered holder of this

Warrant surrendered in connection with the purchase of such shares, and in such

case the Company shall not be required to issue or deliver any certificate until

such tax or other charge has been paid or it has been established to the

Company's satisfaction that no tax or other charge is due.

 

     4. TRANSFER AND EXCHANGE.

 

     4.1. TRANSFER. Subject to the terms hereof, including, without limitation,

Sections 5.1 and 5.3, this Warrant and all rights thereunder are transferable,

in whole or in part, on the books of the Company maintained for such purpose at

its office designated in Section 8.4 hereof by the registered holder hereof in

person or by duly authorized attorney, upon surrender of this Warrant property

endorsed. Upon any partial exercise or transfer, the Company will issue and

deliver to such holder a new warrant or warrants with respect to the Warrant

Shares not so exercised, converted or transferred. Each taker and holder of the

Warrant, by taking or holding the same, consents and agrees that this Warrant

when endorsed in blank shall be deemed negotiable, and that when this Warrant

shall have been so endorsed, the holder may be treated by the Company and all

other persons dealing with this Warrant as the absolute owner of such Warrant

for any purpose and as the person entitled to exercise the rights represented

thereby, or to the transfer on the books of the Company, any notice to the

contrary notwithstanding; but until such transfer on such books, the Company may

treat the registered holder of this Warrant as the owner for all purposes. The

term "Warrant" as used herein shall include this Warrant and, any warrants

delivered in substitution or exchange therefor as provided herein.

 

 

                                       3

<PAGE>

     4.2. EXCHANGE. The Warrant is exchangeable for a warrant or warrants for

the same aggregate number of Warrant Shares, each new Warrant to represent the

right to purchase such number of Warrant Shares as the holder shall designate at

the time of such exchange. The Warrant may be subdivided, at the Warrantholder's

option, into several warrants to purchase the Warrant Shares (collectively, also

referred to as the "Warrant"). Such subdivision may be accomplished in

accordance with the provisions of this Section 4.

 

     5. TRANSFER OF SECURITIES

 

     5.1. RESTRICTIONS ON TRANSFER. Neither this Warrant nor the Warrant Shares

shall be transferable except upon the conditions specified in this Section 5.1,

which conditions are intended to insure compliance with the provisions of the

Securities Act of 1933, as amended (the "Securities Act") in respect to the

transfer of this Warrant and the Warrant Shares.

 

          5.1.1. Unless and until otherwise permitted by this Section 5.1, this

Warrant and each certificate or other document evidencing any of the Warrant

Shares shall be endorsed with the legends substantially in the following form:

 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS

AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS (A)

COVERED BY AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT, (B) THE COMPANY

HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE

COMPANY TO THE EFFECT THAT NO REGISTRATION IS REQUIRED FOR SUCH TRANSFER OR (C)

SUCH TRANSFER IS MADE IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER

THE ACT. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS

IN COMPLIANCE WITH THE ACT.

 

The foregoing legend shall be removed from the certificates representing any

Warrant Shares, at the request of the Warrantholder, (x) upon any sale pursuant

to an effective registration statement under the Securities Act, Section 4(1) of

the Securities Act or Rule 144 under the Securities Act or (y) at such time as

they become eligible for sale under Rule 144(k) under the Securities Act.

 

THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN

VOTING AGREEMENTS AS SET FORTH IN A STOCKHOLDERS' VOTING AGREEMENT, AS AMENDED

FROM TIME TO TIME, BY AND AMONG THE REGISTERED OWNER OF THIS CERTIFICATE, THE

COMPANY AND CERTAIN OTHER STOCKHOLDERS OF THE COMPANY, A COPY OF WHICH IS

AVAILABLE FOR INSPECTION AT THE OFFICES OF THE SECRETARY OF THE COMPANY.

 

THE SALE OR OTHER DISPOSITION OF ANY OF THE SHARES REPRESENTED BY THIS

CERTIFICATE IS RESTRICTED BY A RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT,

DATED AS OF SEPTEMBER __, 2001 AS AMENDED FROM TIME TO TIME, AMONG CERTAIN OF

THE STOCKHOLDERS OF THIS COMPANY AND THIS COMPANY (THE "AGREEMENT"). A COPY OF

THE AGREEMENT IS AVAILABLE FOR INSPECTION DURING NORMAL BUSINESS HOURS AT THE

PRINCIPAL EXECUTIVE OFFICE OF THIS COMPANY.

 

          5.1.2. Neither this Warrant nor the Warrant Shares shall be

transferred and the Company shall not be required to register any such transfer,

unless and until one of the following events shall have occurred:

 

     (a) (i) the Warrant or the Warrant Shares, as the case may be, first shall

have been registered under the Securities Act, or (ii) the Company first shall

have been furnished with an opinion of legal counsel, reasonably satisfactory to

the Company, to the effect that such sale or transfer is exempt from the

registration requirements of the Securities Act.

 

     (b) Notwithstanding the foregoing, no registration or opinion of counsel

shall be required for (i) a transfer by a Warrantholder to an affiliate (as such

term is defined in the Securities Act) of such Warrantholder, (ii) a transfer by

a Warrantholder which is a partnership to a partner of such partnership or a

retired partner of such

 

 

                                       4

<PAGE>

partnership who retires after the date hereof, or to the estate of any such

partner or retired partner, or (iii) a transfer by a Warrantholder which is a

limited liability company to a member of such limited liability company or a

retired member who resigns after the date hereof or to the estate of any such

member or retired member; provided that the transferee in each case agrees in

writing to be subject to the terms of this Section 5 to the same extent as if it

were the original Warrantholder hereunder, or (iv) a transfer made in accordance

with Rule 144 under the Securities Act.

 

     (c) For purposes of this Section 5, "Warrant Shares" shall mean the Warrant

Shares and any other shares of capital stock of the Company issued in respect of

such shares (as a result of stock splits, stock dividends, reclassifications,

recapitalizations, or similar events).

 

     5.2. COOPERATION. The Company shall cooperate in supplying such information

as may be reasonably requested by the Warrantholder to complete and file any

information reporting forms presently or subsequently required by the Commission

as a condition to the availability of an exemption, presently existing or

subsequently adopted, from the Securities Act for the sale of this Warrant or

Warrant Shares.

 

     5.3. PERMITTED TRANSFERS. The Warrantholder may, subject to all applicable

laws and rules, transfer this Warrant and any Warrant Shares purchased

hereunder.

 

     6. ADJUSTMENTS TO EXERCISE PRICE AND WARRANT SHARES. The Exercise Price in

effect from time to time and the number of Warrant Shares shall be subject to

adjustment in certain cases as set forth in this Section 6.

 

     6.1. SUBDIVISION OR COMBINATION. In the event the outstanding shares of the

Warrant Class shall be subdivided into a greater number of shares of such class,


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more